A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus

被引：25
作者：
Thondam, S. K. [1 ]
Cuthbertson, D. J. [1 ]
Aditya, B. S. [1 ]
MacFarlane, I. A. [1 ]
Wilding, J. P. [1 ]
Daousi, C. [1 ]
机构：
[1] Univ Liverpool, Dept Obes & Endocrinol, Aintree Univ Hosp NHS Fdn Trust Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
CLINICAL ENDOCRINOLOGY | 2012年 / 77卷 / 04期
关键词：
FOOD-INTAKE; WEIGHT; HUMANS; DAMAGE;
D O I：
10.1111/j.1365-2265.2012.04368.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：635 / 637
页数：3
相关论文
共 50 条
  • [31] Physiology and pharmacology of glucagon-like peptide-1 receptor
    Kurkin, D. V.
    Bakulin, D. A.
    Morkovin, E. I.
    Petrov, V. I.
    Strygin, A. V.
    Koryanova, K. N.
    Gorbunova, Yu. V.
    Kolosov, Yu. A.
    Ivanova, O. V.
    Pavlova, E. V.
    Dzhavahyan, M. A.
    Zaborovsky, A. V.
    Saparova, V. B.
    Makarenko, I. E.
    Drai, R. I.
    Chumachenko, A. N.
    PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA, 2023, 11 (04): : 347 - 380
  • [32] Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity
    Yao, Zhihong
    Wang, Chen
    Zhu, Qianqian
    Sun, Lidan
    Zhou, Qiang
    Han, Jing
    Wang, Wenxi
    Bhawal, Ruchika
    PEPTIDES, 2023, 162
  • [33] Harnessing the weight-regulating properties of glucagon-like peptide-1 in the treatment of type 2 diabetes
    Sesti, G.
    DIABETES OBESITY & METABOLISM, 2009, 11 : 4 - 10
  • [34] IUPHAR review - Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
    Bruns, Nicolaus
    Tressler, Elizabeth H.
    Vendruscolo, Leandro F.
    Leggio, Lorenzo
    Farokhnia, Mehdi
    PHARMACOLOGICAL RESEARCH, 2024, 207
  • [35] Glucagon-like peptide-1 receptor agonist stimulates mitochondrial bioenergetics in human adipocytes
    Goralska, Joanna
    Sliwa, Agnieszka
    Gruca, Anna
    Razny, Urszula
    Chojnacka, Monika
    Polus, Anna
    Solnica, Bogdan
    Malczewska-Malec, Malgorzata
    ACTA BIOCHIMICA POLONICA, 2017, 64 (03) : 423 - 429
  • [36] Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus
    Bae, Jae Hyun
    Choi, Hyung Jin
    Cho, Kang Ik Kevin
    Kim, Lee Kyung
    Kwon, Jun Soo
    Cho, Young Min
    DIABETES & METABOLISM JOURNAL, 2020, 44 (02) : 248 - 259
  • [37] Discovery of novel OXM-based glucagon-like peptide 1 (GLP-1)/glucagon receptor dual agonists
    Zhang, Xiaolong
    Cai, Yuchen
    Yao, Zhihong
    Chi, Heng
    Li, Yan
    Shi, Jingjing
    Zhou, Zhongbo
    Sun, Lidan
    PEPTIDES, 2023, 161
  • [38] Emerging glucagon-like peptide 1 receptor agonists for the treatment of obesity
    Jepsen, Mathies M.
    Christensen, Mikkel B.
    EXPERT OPINION ON EMERGING DRUGS, 2021, 26 (03) : 231 - 243
  • [39] Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials
    Martinelli, Silvia
    Mazzotta, Alessandro
    Longaroni, Mattia
    Petrucciani, Niccolo
    DRUG AND ALCOHOL DEPENDENCE, 2024, 264
  • [40] Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist
    Parker, Victoria E. R.
    Robertson, Darren
    Wang, Tao
    Hornigold, David C.
    Petrone, Marcella
    Cooper, Aidan T.
    Posch, Maximilian G.
    Heise, Tim
    Plum-Moerschel, Leona
    Schlichthaar, Heike
    Klaus, Beate
    Ambery, Philip D.
    Meier, Juris J.
    Hirshberg, Boaz
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (03) : 803 - 820
12345